Skip to main content
. 2001 Nov;52(5):529–538. doi: 10.1046/j.0306-5251.2001.01493.x

Figure 1.

Figure 1

a) Mean plasma concentrations of budesonide after intravenous administration of 200 µg (n = 21), and after a single dose inhalation of 1000 µg and repeated dose inhalations of 1000 µg twice daily for 7 days via Turbuhaler (n = 21). ▵=Intravenous administration, ○=Budesonide Turbuhaler, single dose inhalation, (□=Budesonide Turbuhaler, repeated dose inhalation.b) Mean plasma concentrations of fluticasone after intravenous administration of 200 µg (n = 21) and after a single dose inhalation of 1000 µg after inhalation and repeated dose inhalations of 1000 µg twice daily for 7 days via pMDI (n = 13) and Diskus (n = 21). ▵=Intravenous administration, ○=Fluticasone Diskus, single dose inhalation, □=Fluticasone Diskus, repeated dose inhalation, +=Fluticasone pMDI, single dose inhalation, ◊=Fluticasone pMDI, repeated dose inhalation.